Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Radiotherapy-related Cognitive Impairment
NCT03907371Phase 2Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- May 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in cognitive impairment, sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
donepezil
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT03907371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03907371.